Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping

Athletes who abuse recombinant human erythropoietin (rhEPO) consider only the benefit to performance and usually ignore the potential short and long-term liabilities. Elevated haematocrit and dehydratation associated with intense exercise may reveal undetected cardiovascular risk, but the mechanisms...

Full description

Bibliographic Details
Main Author: Piloto, Nuno (author)
Other Authors: Teixeira, Helena M. (author), Teixeira-Lemos, Edite (author), Parada, Belmiro (author), Garrido, Patrícia (author), Sereno, José (author), Pinto, Rui (author), Carvalho, Lina (author), Costa, Elísio (author), Belo, Luís (author), Santos-Silva, Alice (author), Teixeira, Frederico (author), Reis, Flávio (author)
Format: article
Language:eng
Published: 2010
Subjects:
rhEPO
Doping
Chronic aerobic exercise
Cardiovascular and mortality risk
Online Access:http://hdl.handle.net/10400.14/3732
Country:Portugal
Oai:oai:repositorio.ucp.pt:10400.14/3732

Internet

http://hdl.handle.net/10400.14/3732

Similar Items